Abstract
visit post registration (20) . We only considered the first occurrence of pneumonia during the 1 study period excluding all subsequent pneumonia events and all subjects with a previous 2 history of pneumonia. To restrict our cases to only those with community-acquired 3 pneumonia, we excluded all potential hospital-acquired infections by keeping only hospital 4 admissions where the first primary diagnosis (reason for admission) was for pneumonia and 5 excluding all pneumonia records within 14 days after hospital discharge in either primary or 6 secondary care, consistently with what has been described in previous studies (3, 21, 22) 7 (Supplementary Figure 1) . Finally, we separately analysed the first incidence of community- 
21

Covariates
22
Covariates included sex, age (0-64 and ≥ 65), calendar-year (1997-2004 and 2005-2011) , 23 body mass index (BMI Kg/m 2 ), smoking status (non-smokers, including ex-smokers and basis that all could be potentially related to coeliac disease and pneumonia (2, 3, (23) (24) (25) (26) . We 1 extracted all covariates data from CPRD. BMI was classified as underweight (≤ 18.5), 2 normal weight (>18.5-25), overweight (>25-30) and obese (>30). Comorbidities were defined 3 using the Charlson index (27), details of which are reported elsewhere (28), and categorised 4 as no comorbidity (Charlson index=0) or more than one comorbidity (Charlson index≥1). We 5 considered the last record reported in CPRD before the study end for smoking, BMI and 6 comorbidities. Socioeconomic status was categorised by the quintile of the rank of a 7 patient's area of residence by the Indices of Multiple Deprivation (29). 
Statistical analysis
10
We calculated overall pneumonia rates per 1000 person-years among subjects with and 11 without coeliac disease. We assessed unvaccinated and vaccinated periods of time separately.
12
We then used a Cox regression model to estimate the hazard ratios (HR) of community-13 acquired pneumonia during unvaccinated and vaccinated periods in patients with coeliac 14 disease after diagnosis compared to controls after testing for the proportional hazards 15 assumption. All HRs were adjusted for sex, age, calendar-year, BMI, smoking status,
16
socioeconomic status, and number of comorbidities (when the models were not stratified by 17 these variables). We assessed for possible interactions between coeliac disease and all of the 18 above covariates using a likelihood ratio test (LRT).
19
We then assessed how rates of pneumonia in unvaccinated patients varied in relation to the 20 time of coeliac disease diagnosis (Figure 1 ). 
Sensitivity analysis
10
We increased the specificity of our coeliac disease definition by repeating our analysis for 11 community-acquired pneumonia after restricting our population with coeliac disease to those 12 who, in addition to one diagnostic code of coeliac disease, had either a relevant prescription 13 for a gluten-free product or a second documented record of their disease. 53% lower risk than vaccinated controls of the same age (HR 0.47, 95% CI 0.27-0.84).
Results
13
Finally, there was a significant interaction between coeliac disease and age categorised as 0- 
Risk of first community-acquired pneumonia and pneumococcal
1 pneumonia before and after coeliac disease diagnosis in unvaccinated
Having detected a statistically significant higher risk of pneumonia in unvaccinated patients 4 with coeliac disease compared to unvaccinated controls and a significant interaction with age,
5
we limited the analysis to time when patients were unvaccinated and aged less than 65 years improve on a gluten free diet (8, 9), it does not affect childhood coeliac disease (7) and it is 23 more frequent in people with coeliac disease with associated autoimmune diseases and with other complications (refractory coeliac disease, lymphoma, ulcerative jejunoileitis) 1 (10).
3
Implications for clinical practice 4 We have found that unvaccinated people under the age of 65 with coeliac disease have an 5 excess risk of community-acquired pneumonia and specifically pneumococcal pneumonia.
6
Our work shows that only 26.6% underwent vaccination after an average time of 6.7 years 7 from coeliac disease diagnosis. In the patient group with the highest relative risk, those 
